MI-1061
MI-1061 is a potent, orally bioavailable, and chemically stable MDM2 (MDM2-p53 interaction) inhibitor (IC50=4.4 nM; Ki=0.16 nM) . MI-1061 potently activates p53 and induces apoptosis in the SJSA-1 xenograft tumor tissue in mice. Anti-tumor activity[1].
Product Specifications
CAS Number
[1410737-34-6]
UNSPSC
12352005
Target
Apoptosis; E1/E2/E3 Enzyme; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mi-1061.html
Purity
99.72
Solubility
DMSO : 160 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=C(NC([C@H](N2)[C@H](C3=CC=CC(Cl)=C3F)[C@]4(C(NC5=C4C=CC(Cl)=C5)=O)C62CCCCC6)=O)C=C1
Molecular Formula
C30H26Cl2FN3O4
Molecular Weight
582.45
References & Citations
[1]Aguilar A, et al. Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannichring-opening-cyclization reaction mechanism in spiro-oxindoles. J Med Chem. 2014 Dec 26;57 (24) :10486-98.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
138281-Biotin 100 µL
RAGE (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (Biotin)
Sign In for Pricing
View Details 
MBS6282618-01 0.2 mL
CCR4, CT (CCR4, CMKBR4, C-C chemokine receptor type 4, K5-5, CD194) (PE)
Sign In for Pricing
View Details MBS6282618-02 5x 0.2 mL
CCR4, CT (CCR4, CMKBR4, C-C chemokine receptor type 4, K5-5, CD194) (PE)
Sign In for Pricing
View Details 
HEA5638 10 / PCK
Stirrer bars 10/6mm for Electrothermal STEM Integrity 10 system
Sign In for Pricing
View Details sc-252243 1 g
(4S,5S) -2,2-Dimethyl-α, α, α', α'-tetraphenyldioxolane-4,5-dimethanol
Sign In for Pricing
View Details